Filed 3.4y ago· Jan 20, 2023
39 days to disclose
Christopher L. Jacobs
RHouseNew York-27
↓sold
Uranium Energy
UEC
$1K-$15K
+36.4% vs S&P 500
Trade dateDec 12, 2022
Stock trades that members of the U.S. House and Senate disclose, by law, after they buy or sell. Pulled straight from the official government websites — typically posted within hours of being filed.




































































































| Filed | Politician | Type | Stock | Trade date | Smart move? | Size |
|---|---|---|---|---|---|---|
Jan 20, 2023 3.4y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↓sold | Uranium Energy UEC | Dec 12, 2022 39 days to disclose | Flat·+0.0% +36.4% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 20, 2023 3.4y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↑bought | First Horizon FHN | Dec 12, 2022 39 days to disclose | Good buy·+$186+2.3% −45.9% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 20, 2023 3.4y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↑bought | Kalvista Pharmaceuticals KALV | Dec 12, 2022 39 days to disclose | Good buy·+$28.2K+352.1% +264.0% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 20, 2023 3.4y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↓sold | Anavex Life Sciences AVXL | Dec 12, 2022 39 days to disclose | Flat·+0.0% +88.1% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 20, 2023 3.4y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↑bought | Biolife Solutions BLFS | Dec 12, 2022 39 days to disclose | Good buy·+$824+10.3% −77.8% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 20, 2023 3.4y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↓sold | Crescent Energy CRGY | Dec 12, 2022 39 days to disclose | Flat·+0.0% +36.4% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 20, 2023 3.4y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↓sold | Coterra Energy CTRA | Dec 12, 2022 39 days to disclose | Flat·+0.0% +36.4% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 20, 2023 3.4y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↓sold | Cogent Biosciences COGT | Dec 12, 2022 39 days to disclose | Flat·+0.0% +6.5% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 20, 2023 3.4y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↑bought | Claros Mortgage Trust CMTG | Dec 12, 2022 39 days to disclose | Bad buy·−$6.8K-84.9% −133.1% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 20, 2023 3.4y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↑bought | Chord Energy CHRD | Dec 12, 2022 39 days to disclose | Good buy·+$460+5.7% −30.6% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 20, 2023 3.4y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↑bought | Chevron CVX | Dec 12, 2022 39 days to disclose | Good buy·+$726+9.1% −27.3% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 20, 2023 3.4y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↑bought | Borr Drilling Ltd. BORR | Dec 12, 2022 39 days to disclose | Good buy·+$3.3K+41.4% +5.0% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 20, 2023 3.4y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↑bought | Archrock AROC | Dec 12, 2022 39 days to disclose | Good buy·+$29.4K+367.7% +279.6% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 20, 2023 3.4y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↑bought | Krystal Biotech KRYS | Dec 12, 2022 39 days to disclose | Good buy·+$24.2K+302.8% +296.3% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 20, 2023 3.4y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↓sold | Bank of America BAC | Dec 12, 2022 39 days to disclose | Flat·+0.0% +48.2% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 20, 2023 3.4y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↓sold | Athira Pharma, Inc ATHA Athira Pharma | Dec 12, 2022 39 days to disclose | price pending | $1K-$15K midpoint $8K |
Jan 20, 2023 3.4y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↑bought | Berkshire Hathaway BRK.B | Dec 12, 2022 39 days to disclose | price pending | $1K-$15K midpoint $8K |
Jan 20, 2023 3.4y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↑bought | M MNRL | Dec 12, 2022 39 days to disclose | price pending | $1K-$15K midpoint $8K |
Jan 20, 2023 3.4y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↓sold | Cassava Sciences, Inc SAVA Cassava Sciences | Dec 12, 2022 39 days to disclose | price pending | $1K-$15K midpoint $8K |
Jan 20, 2023 3.4y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↑bought | C CIVI Civitas Resources | Dec 12, 2022 39 days to disclose | price pending | $1K-$15K midpoint $8K |
Jan 20, 2023 3.4y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↓sold | Expro Group Holdings N.v. XPRO | Dec 12, 2022 39 days to disclose | Flat·+0.0% +88.1% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 20, 2023 3.4y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↑bought | ExxonMobil XOM Exxon Mobil | Dec 12, 2022 39 days to disclose | Good buy·+$3.3K+40.9% +4.5% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 20, 2023 3.4y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↓sold | Helix Energy Solutions HLX | Dec 12, 2022 39 days to disclose | Flat·+0.0% +36.4% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 20, 2023 3.4y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↓sold | Helmerich & Payne HP | Dec 12, 2022 39 days to disclose | Flat·+0.0% +88.1% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 20, 2023 3.4y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↓sold | Home Depot HD | Dec 12, 2022 39 days to disclose | Flat·+0.0% +70.9% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 20, 2023 3.4y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↑bought | Inotiv NOTV | Dec 12, 2022 39 days to disclose | Bad buy·−$7.4K-92.9% −181.0% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 20, 2023 3.4y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↑bought | Stock When Issued INSW.V | Dec 12, 2022 39 days to disclose | price pending | $1K-$15K midpoint $8K |
Jan 20, 2023 3.4y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↓sold | Gevo GEVO | Dec 12, 2022 39 days to disclose | Flat·+0.0% +88.1% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 20, 2023 3.4y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↓sold | Meta Platforms META Meta Platforms, Inc. - Class A | Dec 12, 2022 39 days to disclose | Flat·+0.0% +176.8% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 20, 2023 3.4y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↑bought | National Energy Services Reunited NESR Corp. - Ordinary Shares | Dec 12, 2022 39 days to disclose | price pending | $1K-$15K midpoint $8K |
Jan 20, 2023 3.4y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↑bought | Netstreit NTST | Dec 12, 2022 39 days to disclose | Good buy·+$531+6.6% −81.5% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 20, 2023 3.4y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↑bought | Permian Resources PR A | Dec 12, 2022 39 days to disclose | Good buy·+$10.8K+134.6% +98.2% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 20, 2023 3.4y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↑bought | Healthpeak Properties DOC Shares of Beneficial Interest | Dec 12, 2022 39 days to disclose | Bad buy·−$1.8K-22.9% −38.7% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 20, 2023 3.4y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↑bought | Pioneer Natural PXD | Dec 12, 2022 39 days to disclose | price pending | $1K-$15K midpoint $8K |
Jan 20, 2023 3.4y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↓sold | Relmada Therapeutics RLMD | Dec 12, 2022 39 days to disclose | Flat·+0.0% +6.5% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 20, 2023 3.4y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↑bought | S SWTX common stock | Dec 12, 2022 39 days to disclose | price pending | $1K-$15K midpoint $8K |
Jan 20, 2023 3.4y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↓sold | Tellurian Inc TELL Tellurian | Dec 12, 2022 39 days to disclose | price pending | $1K-$15K midpoint $8K |
Jan 20, 2023 3.4y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↓sold | Tesla TSLA | Dec 12, 2022 39 days to disclose | Flat·+0.0% +70.9% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 20, 2023 3.4y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↑bought | Kura Oncology KURA | Dec 6, 2022 45 days to disclose | Bad buy·−$12.3K-37.8% −128.4% vs S&P 500 | $15K-$50K midpoint $32.5K |
Dec 12, 2022 3.5y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↑bought | Relmada Therapeutics RLMD | Nov 8, 2022 34 days to disclose | Good buy·+$2.5K+31.0% +19.2% vs S&P 500 | $1K-$15K midpoint $8K |
Dec 12, 2022 3.5y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↑bought | Uranium Energy UEC | Nov 8, 2022 34 days to disclose | Good buy·+$23.5K+294.3% +269.9% vs S&P 500 | $1K-$15K midpoint $8K |
Dec 12, 2022 3.5y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↓sold | Sabra Health Care Reit SBRA | Nov 8, 2022 34 days to disclose | Flat·+0.0% +22.8% vs S&P 500 | $1K-$15K midpoint $8K |
Dec 12, 2022 3.5y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↑bought | Johnson & Johnson JNJ | Nov 8, 2022 34 days to disclose | Good buy·+$2.6K+33.1% +21.3% vs S&P 500 | $1K-$15K midpoint $8K |
Dec 12, 2022 3.5y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↑bought | Home Depot HD | Nov 8, 2022 34 days to disclose | Good buy·+$500+6.2% −69.2% vs S&P 500 | $1K-$15K midpoint $8K |
Dec 12, 2022 3.5y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↑bought | Helix Energy Solutions HLX | Nov 8, 2022 34 days to disclose | Good buy·+$3.5K+43.8% +19.5% vs S&P 500 | $1K-$15K midpoint $8K |
Dec 12, 2022 3.5y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↑bought | Gevo GEVO | Nov 8, 2022 34 days to disclose | Bad buy·−$646-8.1% −104.6% vs S&P 500 | $1K-$15K midpoint $8K |
Dec 12, 2022 3.5y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↑bought | Flex Lng Ltd. FLNG | Nov 8, 2022 34 days to disclose | Bad buy·−$628-7.8% −32.1% vs S&P 500 | $1K-$15K midpoint $8K |
Dec 12, 2022 3.5y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↑bought | Bank of America BAC | Nov 8, 2022 34 days to disclose | Good buy·+$3.3K+41.4% −9.1% vs S&P 500 | $1K-$15K midpoint $8K |
Dec 12, 2022 3.5y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↑bought | AGNC Investment AGNC | Nov 8, 2022 34 days to disclose | Good buy·+$2.1K+26.1% +3.2% vs S&P 500 | $1K-$15K midpoint $8K |
Dec 12, 2022 3.5y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↓sold | Akero Therapeutics AKRO Akero Therapeutics | Nov 8, 2022 34 days to disclose | price pending | $1K-$15K midpoint $8K |
Dec 12, 2022 3.5y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↓sold | Athira Pharma, Inc ATHA Athira Pharma | Nov 8, 2022 34 days to disclose | price pending | $1K-$15K midpoint $8K |
Dec 12, 2022 3.5y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↑bought | Atreca, Inc. - BCEL | Nov 8, 2022 34 days to disclose | price pending | $1K-$15K midpoint $8K |
Dec 12, 2022 3.5y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↑bought | Berkshire Hathaway BRK.A Berkshire Hathaway | Nov 8, 2022 34 days to disclose | price pending | $1K-$15K midpoint $8K |
Dec 12, 2022 3.5y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↑bought | Cassava Sciences, Inc SAVA Cassava Sciences | Nov 8, 2022 34 days to disclose | price pending | $1K-$15K midpoint $8K |
Dec 12, 2022 3.5y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↓sold | Chevron CVX | Nov 8, 2022 34 days to disclose | Flat·+0.0% +24.3% vs S&P 500 | $1K-$15K midpoint $8K |
Dec 12, 2022 3.5y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↓sold | Enochian Biosciences ENOB Enochian Biosciences | Nov 8, 2022 34 days to disclose | price pending | $1K-$15K midpoint $8K |
Dec 12, 2022 3.5y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↑bought | ExxonMobil XOM Exxon Mobil | Nov 8, 2022 34 days to disclose | Good buy·+$2.5K+31.1% +6.8% vs S&P 500 | $1K-$15K midpoint $8K |
Dec 12, 2022 3.5y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↑bought | H HSAC | Nov 8, 2022 34 days to disclose | price pending | $1K-$15K midpoint $8K |
Dec 12, 2022 3.5y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↓sold | JPMorgan Chase JPM JP Morgan Chase & | Nov 8, 2022 34 days to disclose | Flat·+0.0% +50.5% vs S&P 500 | $1K-$15K midpoint $8K |
Dec 12, 2022 3.5y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↓sold | Kodiak Sciences KOD | Nov 8, 2022 34 days to disclose | Flat·+0.0% +96.5% vs S&P 500 | $1K-$15K midpoint $8K |
Dec 12, 2022 3.5y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↓sold | Healthpeak Properties DOC Shares of Beneficial Interest | Nov 8, 2022 34 days to disclose | Flat·+0.0% +22.8% vs S&P 500 | $1K-$15K midpoint $8K |
Dec 12, 2022 3.5y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↑bought | Plug Power PLUG | Nov 8, 2022 34 days to disclose | Bad buy·−$6.2K-77.7% −113.8% vs S&P 500 | $1K-$15K midpoint $8K |
Dec 12, 2022 3.5y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↓sold | Shoulder Innovations SI Silvergate Capital Corporation Class A | Nov 8, 2022 34 days to disclose | price pending | $1K-$15K midpoint $8K |
Dec 12, 2022 3.5y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↑bought | Tellurian, Inc TLRN Tellurian, Inc, | Nov 8, 2022 34 days to disclose | price pending | $1K-$15K midpoint $8K |
Nov 16, 2022 3.5y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↑bought | JPMorgan Chase JPM JP Morgan Chase & | Oct 18, 2022 29 days to disclose | Good buy·+$12.3K+153.2% +92.6% vs S&P 500 | $1K-$15K midpoint $8K |
Nov 16, 2022 3.5y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↑bought | Pfizer PFE | Oct 12, 2022 35 days to disclose | Bad buy·−$3K-36.9% −58.7% vs S&P 500 | $1K-$15K midpoint $8K |
Nov 16, 2022 3.5y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↑bought | Innovative Industrial Properties IIPR | Oct 12, 2022 35 days to disclose | Bad buy·−$3K-38.0% −69.5% vs S&P 500 | $1K-$15K midpoint $8K |
Nov 16, 2022 3.5y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↑bought | Bank of America BAC | Oct 12, 2022 35 days to disclose | Good buy·+$6.1K+75.8% +4.6% vs S&P 500 | $1K-$15K midpoint $8K |
Nov 16, 2022 3.5y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↑bought | AGNC Investment AGNC | Oct 12, 2022 35 days to disclose | Good buy·+$2.8K+34.9% +3.4% vs S&P 500 | $1K-$15K midpoint $8K |
Nov 16, 2022 3.5y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↑bought | Expro Group Holdings N.v. XPRO | Oct 12, 2022 35 days to disclose | Good buy·+$665+8.3% −102.2% vs S&P 500 | $1K-$15K midpoint $8K |
Nov 16, 2022 3.5y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↑bought | C CIVI Civitas Resources | Oct 12, 2022 35 days to disclose | price pending | $1K-$15K midpoint $8K |
Nov 16, 2022 3.5y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↑bought | IVERIC bio, Inc ISEE IVERIC bio | Oct 12, 2022 35 days to disclose | price pending | $1K-$15K midpoint $8K |
Nov 16, 2022 3.5y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↑bought | Amylyx Pharmaceuticals AMLX | Oct 12, 2022 35 days to disclose | Bad buy·−$4.2K-52.2% −162.7% vs S&P 500 | $1K-$15K midpoint $8K |
Nov 16, 2022 3.5y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↑bought | Anavex Life Sciences AVXL | Oct 12, 2022 35 days to disclose | Bad buy·−$5.5K-68.4% −178.9% vs S&P 500 | $1K-$15K midpoint $8K |
Nov 16, 2022 3.5y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↑bought | Chevron CVX | Oct 12, 2022 35 days to disclose | Good buy·+$1.4K+17.5% −27.0% vs S&P 500 | $1K-$15K midpoint $8K |
Nov 16, 2022 3.5y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↑bought | ExxonMobil XOM Exxon Mobil | Oct 12, 2022 35 days to disclose | Good buy·+$4.1K+51.8% +7.4% vs S&P 500 | $1K-$15K midpoint $8K |
Nov 16, 2022 3.5y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↓sold | B BRMK | Oct 7, 2022 40 days to disclose | price pending | $1K-$15K midpoint $8K |
Nov 16, 2022 3.5y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↓sold | Tellurian Inc TELL Tellurian | Oct 7, 2022 40 days to disclose | price pending | $1K-$15K midpoint $8K |
Sep 9, 2022 3.7y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↓sold | Issued VTRSV | Jul 18, 2022 53 days to disclose · 8 past 45-day window | price pending | $1K-$15K midpoint $8K |
Sep 9, 2022 3.7y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↑bought | Shoulder Innovations SI Silvergate Capital Corporation Class A | Jul 18, 2022 53 days to disclose · 8 past 45-day window | price pending | $1K-$15K midpoint $8K |
Sep 9, 2022 3.7y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↑bought | Tellurian Inc TELL Tellurian | Jul 18, 2022 53 days to disclose · 8 past 45-day window | price pending | $1K-$15K midpoint $8K |
Sep 9, 2022 3.7y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↓sold | Vertex Energy, Inc VTNR Vertex Energy | Jul 18, 2022 53 days to disclose · 8 past 45-day window | price pending | $1K-$15K midpoint $8K |
Sep 9, 2022 3.7y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↓sold | Healthpeak Properties DOC Shares of Beneficial Interest | Jul 18, 2022 53 days to disclose · 8 past 45-day window | Flat·+0.0% +10.1% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 9, 2022 3.7y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↑bought | Kite Realty Group Trust KRG | Jul 18, 2022 53 days to disclose · 8 past 45-day window | Good buy·+$4K+49.8% +39.7% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 9, 2022 3.7y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↓sold | Home Depot HD | Jul 18, 2022 53 days to disclose · 8 past 45-day window | Flat·+0.0% +64.5% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 9, 2022 3.7y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↑bought | Inotiv NOTV | Jul 18, 2022 53 days to disclose · 8 past 45-day window | Bad buy·−$7.8K-97.6% −194.1% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 9, 2022 3.7y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↓sold | First Horizon FHN | Jul 18, 2022 53 days to disclose · 8 past 45-day window | Flat·+0.0% +63.8% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 9, 2022 3.7y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↓sold | Innovative Industrial Properties IIPR | Jul 18, 2022 53 days to disclose · 8 past 45-day window | Flat·+0.0% +10.1% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 9, 2022 3.7y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↓sold | Scorpio Tankers STNG | Jul 18, 2022 53 days to disclose · 8 past 45-day window | Flat·+0.0% +96.5% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 9, 2022 3.7y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↓sold | Antero Resources AR | Jul 18, 2022 53 days to disclose · 8 past 45-day window | Flat·+0.0% +64.9% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 9, 2022 3.7y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↑bought | Associated Banc-Corp ASBC | Jul 18, 2022 53 days to disclose · 8 past 45-day window | price pending | $1K-$15K midpoint $8K |
Sep 9, 2022 3.7y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↓sold | Athira Pharma, Inc ATHA Athira Pharma | Jul 18, 2022 53 days to disclose · 8 past 45-day window | price pending | $1K-$15K midpoint $8K |
Sep 9, 2022 3.7y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↓sold | Cassava Sciences, Inc SAVA Cassava Sciences | Jul 18, 2022 53 days to disclose · 8 past 45-day window | price pending | $1K-$15K midpoint $8K |
Sep 9, 2022 3.7y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↓sold | C CDEV | Jul 18, 2022 53 days to disclose · 8 past 45-day window | price pending | $1K-$15K midpoint $8K |
Sep 9, 2022 3.7y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↑bought | C CIVI Civitas Resources | Jul 18, 2022 53 days to disclose · 8 past 45-day window | price pending | $1K-$15K midpoint $8K |
Sep 9, 2022 3.7y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↑bought | Crescent Energy CRGY | Jul 18, 2022 53 days to disclose · 8 past 45-day window | Good buy·+$93+1.2% −63.8% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 9, 2022 3.7y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↑bought | E ESTE | Jul 18, 2022 53 days to disclose · 8 past 45-day window | price pending | $1K-$15K midpoint $8K |
Sep 9, 2022 3.7y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↑bought | Enochian Biosciences ENOB Enochian Biosciences | Jul 18, 2022 53 days to disclose · 8 past 45-day window | price pending | $1K-$15K midpoint $8K |
Sep 9, 2022 3.7y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↓sold | ExxonMobil XOM Exxon Mobil | Jul 18, 2022 53 days to disclose · 8 past 45-day window | Flat·+0.0% +64.9% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 9, 2022 3.7y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↓sold | G GNKOQ | Jul 18, 2022 53 days to disclose · 8 past 45-day window | price pending | $1K-$15K midpoint $8K |